A detailed history of Park Avenue Securities LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 1,945 shares of LNTH stock, worth $218,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,945
Previous 3,072 36.69%
Holding current value
$218,812
Previous $247,000 13.77%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$77.7 - $123.62 $87,567 - $139,319
-1,127 Reduced 36.69%
1,945 $213,000
Q2 2024

Jul 09, 2024

BUY
$58.87 - $83.05 $180,848 - $255,129
3,072 New
3,072 $247,000
Q4 2023

Jan 10, 2024

BUY
$55.6 - $77.89 $17,069 - $23,912
307 Added 7.71%
4,290 $266,000
Q3 2023

Oct 26, 2023

BUY
$60.27 - $90.75 $240,055 - $361,457
3,983 New
3,983 $277,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.73B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.